Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor

• 收藏
• 分享

专利权人:

JIANGSU HENGRUI MEDICINE CO.; LTD.

发明人:

Lu, Yun,Shao, Qiyun,Wu, Guaili,Feng, Jun

申请号：

AU2017277002

公开号：

AU2017277002A1

申请日:

2017.06.06

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Provided is a pharmaceutically acceptable salt as a renal outer medullary potassium channel (ROMK) inhibitor, specifically an L-tartrate and a crystal form I and crystal form II thereof. The pharmaceutically acceptable salt of the ROMK inhibitor, specifically the L-tartrate, has improved bioavailability and stability.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/